Insider filing · EWTX
Peter A. Thompson
Director
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 28 filings in 24 months
ticker →
Peter A. Thompson bought $10.0M of Edgewise Therapeutics (EWTX)
Executed Apr 3 2025, disclosed Apr 4 2025, 1 day later.
Value, as filed
$10.0M
496,771 sh across 2 lots
Executed
Apr 3 2025
the trade date, as filed
Disclosed
Apr 4 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
+30.5%
+13.5% from execution
Over the 21 trading sessions from the disclosed entry session (Apr 4 2025), the stock returned +30.5% (delay-adjusted); from the execution session (Apr 3 2025), +13.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
PTPeter A. Thompson (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Sionna Therapeutics, Inc. (SION). The largest single filing was $22.9M of SION (510,583 sh across 3 lots, as filed), executed Apr 14.
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→